Point-of-care (POC) versus central laboratory instrumentation for monitoring oral anticoagulation

Vascular Medicine

Volumn 10, Issue 1, 2005, Pages 23-27

  Dorfman, David M ^a   Goonan, Ellen M ^a   Boutilier, M Kay ^a   Jarolim, Petr ^a   Tanasijevic, Milenko ^a   Goldhaber, Samuel Z ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

International normalized ratio (INR); Prothrombin time (PT); Warfarin

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

ACCURACY; ANTICOAGULANT THERAPY; ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG DOSE REDUCTION; DRUG MONITORING; HEART ATRIUM FIBRILLATION; HEART VALVE PROSTHESIS; HUMAN; INTERNATIONAL NORMALIZED RATIO; LABORATORY TEST; MAJOR CLINICAL STUDY; MEASUREMENT; MEDICAL INSTRUMENTATION; MONITOR; PHYSICIAN; PRIORITY JOURNAL; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; HUMANS; INTERNATIONAL NORMALIZED RATIO; POINT-OF-CARE SYSTEMS; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; WARFARIN;

EID: 18744368533     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1191/1358863x05vm587oa     Document Type: Article

References (11)

1. Zimmerman CR. The role of point-of-care anticoagulation monitoring in arterial and venous thromboembolic disorders. J Thromb Thrombolysis 2000; 9: 187-98.
2. Van den Besselaar AMHP, Meeuwisse-Braun J, Schaefer-van Mansfeld H et al. A comparison between capillary and venous blood international normalized ratio determinations in a portable prothrombin time device. Blood Coagul Fibrinolysis 2000; 11: 559-62.
3. Bland JM, Altman DG. Statistical method for assessing agreement between two methods of clinical measurement. Lancet 1986; i: 307-10.
4. Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res 1999; 8: 135-60.
5. Gosselin R, Owings JT, White RH et al. A comparison of point-of-care instruments designed for monitoring oral anticoagulation with standard laboratory methods. Thromb Haemost 2000; 83: 698-703.
6. Van den Besselar AMHP. A comparison of INRs determined with a whole blood prothrombin time device and two international reference preparations for thromboplastin. Thromb Haemost 2000; 84: 410-12.
7. Kemme MJB, Faaij RA, Schoemaker RC et al. Disagreement between bedside and laboratory activated partial thromboplastin time and international normalized ratio for various novel anticoagulants. Blood Coagul Fibrinolysis 2001; 12: 583-91.
8. Grasso-Correnti N, Goldszer RC, Goldhaber SZ. The critical pathways of an anticoagulation service. Critical Pathways in Cardiology 2003; 2: 41-45.
9. Palareti G, Manotti C, D'Angelo A et al. Thrombotic events during oral anticoagulant treatment: results of the inception-cohort, prospective, collaborative ISCOAT Study. ISCOAT study group (Italian Study on Complications of Oral Anticoagulant Therapy). Thromb Haemost 1997; 78: 1438-43.
10. Poller L, Keown M, Chauhan N et al. European concerted action on anticoagulation (ECAA): an assessment of a method for ISI calibration of two whole blood point-of-care PT monitor systems based on lyophilized plasmas using whole blood equivalent PT. J Thromb Haemost 2002; 1: 766-72.
11. Poller L, Keown M, Chauhan N et al. European concerted action on anticoagulation: comparison of fresh plasma and whole blood multicentre ISI calibrations of CoaguChek Mini and TAS PT-NC whole blood prothrombin time point-of-care monitors. Thromb Haemost 2002; 87: 859-66.